Characterization of respiratory syncytial virus M- and M2-specific CD4 T cells in a murine model

Journal of Virology

Volumn 83, Issue 10, 2009, Pages 4934-4941

  Liu, Jie ^a   Ruckwardt, Tracy J ^a   Chen, Man ^a   Johnson, Teresa R ^a   Graham, Barney S ^a  

^a NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; EPITOPE; FLUOROCHROME; GAMMA INTERFERON; INTERLEUKIN 2; PEPTIDE; TETRAMER; TRANSCRIPTION FACTOR FOXP3; HYBRID PROTEIN; VIRUS ANTIGEN; VIRUS PROTEIN;

AMINO ACID SEQUENCE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CD4+ T LYMPHOCYTE; CELL ACTIVATION; CELL DIFFERENTIATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; FEMALE; IMMUNITY; LUNG; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; RESPIRATORY SYNCYTIAL PNEUMOVIRUS; TH1 CELL; TH2 CELL; VIRUS CHARACTERIZATION; VIRUS INFECTION; ANIMAL; BAGG ALBINO MOUSE; C57BL MOUSE; CD8+ T LYMPHOCYTE; CELL CULTURE; DISEASE MODEL; GENE; IMMUNOLOGY; PATHOGENICITY; SPLEEN; VIROLOGY;

MURINAE; MUS; RESPIRATORY SYNCYTIAL VIRUS; RICE STRIPE VIRUS;

ANIMALS; ANTIGENS, VIRAL; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; CELLS, CULTURED; DISEASE MODELS, ANIMAL; EPITOPES, T-LYMPHOCYTE; FEMALE; GENES, MHC CLASS II; INTERFERON-GAMMA; INTERLEUKIN-2; LUNG; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; RECOMBINANT FUSION PROTEINS; RESPIRATORY SYNCYTIAL VIRUS INFECTIONS; RESPIRATORY SYNCYTIAL VIRUSES; SPLEEN; VIRAL PROTEINS;

EID: 65349138165     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.02140-08     Document Type: Article

References (51)

1. Addo, M. M., M. Altfeld, E. S. Rosenberg, R. L. Eldridge, M. N. Philips, K. Habeeb, A. Khatri, C. Brander, G. K. Robbins, G. P. Mazzara, P. J. Goulder, and B. D. Walker. 2001. The HIV-1 regulatory proteins Tat and Rev are frequently targeted by cytotoxic T lymphocytes derived from HIV-1-infected individuals. Proc. Natl. Acad. Sci. USA 98:1781-1786.
2. Alwan, W. H., W. J. Kozlowska, and P. J. Openshaw. 1994. Distinct types of lung disease caused by functional subsets of antiviral T cells. J. Exp. Med. 179:81-89. (Pubitemid 24012973)
3. Aung, S., J. A. Rutigliano, and B. S. Graham. 2001. Alternative mechanisms of respiratory syncytial virus clearance in perforin knockout mice lead to enhanced disease. J. Virol. 75:9918-9924. (Pubitemid 32900126)
4. 8+ respiratory syncytial virus-specific cytotoxic T-lymphocyte activity in vivo. J. Virol. 73:8944-8949.
5. Barouch, D. H., Z. Y. Yang, W. P. Kong, B. Korioth-Schmitz, S. M. Sumida, D. M. Truitt, M. G. Kishko, J. C. Arthur, A. Miura, J. R. Mascola, N. L. Letvin, and G. J. Nabel. 2005. A human T-cell leukemia virus type 1 regulatory element enhances the immunogenicity of human immunodeficiency virus type 1 DNA vaccines in mice and nonhuman primates. J. Virol. 79:8828-8834. (Pubitemid 40934793)
6. + T-cell responses: relationship to viral load in untreated HIV infection. J. Virol. 75:11983-11991.
7. Bingaman, A. W., D. S. Patke, V. R. Mane, M. Ahmadzadeh, M. Ndejembi, S. T. Bartlett, and D. L. Farber. 2005. Novel phenotypes and migratory properties distinguish memory CD4 T cell subsets in lymphoid and lung tissue. Eur. J. Immunol. 35:3173-3186. (Pubitemid 41672522)
8. Bukreyev, A., I. M. Belyakov, G. A. Prince, K. C. Yim, K. K. Harris, J. A. Berzofsky, and P. L. Collins. 2005. Expression of interleukin-4 by recombinant respiratory syncytial virus is associated with accelerated inflammation and a nonfunctional cytotoxic T-lymphocyte response following primary infection but not following challenge with wild-type virus. J. Virol. 79:9515-9526. (Pubitemid 41022295)
9. + T cells. J. Exp. Med. 184:863-871.
10. Chang, J., S. Y. Choi, H. T. Jin, Y. C. Sung, and T. J. Braciale. 2004. Improved effector activity and memory CD8 T cell development by IL-2 expression during experimental respiratory syncytial virus infection. J. Immunol. 172:503-508. (Pubitemid 38020506)
11. Choi, E. H., H. J. Lee, T. Yoo, and S. J. Chanock. 2002. A common haplotype of interleukin-4 gene IL4 is associated with severe respiratory syncytial virus disease in Korean children. J. Infect. Dis. 186:1207-1211. (Pubitemid 35192998)
12. Collins, P. L., and B. S. Graham. 2008. Viral and host factors in human respiratory syncytial virus pathogenesis. J. Virol. 82:2040-2055.
13. + T cells. J. Virol. 66:7444-7451.
14. + T-cell mechanisms in the control of respiratory virus infections. Immunol. Rev. 159:105-117.
15. + regulatory T cells in hepatitis C virus infection. J. Virol. 82:5043-5053.
16. Graham, B. S. 1996. Immunological determinants of disease caused by respiratory syncytial virus. Trends Microbiol. 4:290-293.
17. Graham, B. S., L. A. Bunton, P. F. Wright, and D. T. Karzon. 1991. Role of T lymphocyte subsets in the pathogenesis of primary infection and rechallenge with respiratory syncytial virus in mice. J. Clin. Investig. 88:1026-1033.
18. Graham, B. S., T. H. Davis, Y. W. Tang, and W. C. Gruber. 1993. Immunoprophylaxis and immunotherapy of respiratory syncytial virus-infected mice with respiratory syncytial virus-specific immune serum. Pediatr. Res. 34:167-172. (Pubitemid 23207201)
19. Graham, B. S., G. S. Henderson, Y. W. Tang, X. Lu, K. M. Neuzil, and D. G. Colley. 1993. Priming immunization determines T helper cytokine mRNA expression patterns in lungs of mice challenged with respiratory syncytial virus. J. Immunol. 151:2032-2040. (Pubitemid 23235675)
20. Graham, B. S., M. D. Perkins, P. F. Wright, and D. T. Karzon. 1988. Primary respiratory syncytial virus infection in mice. J. Med. Virol. 26:153-162. (Pubitemid 18242806)
21. Graham, B. S., Y. W. Tang, and W. C. Gruber. 1995. Topical immunoprophylaxis of respiratory syncytial virus (RSV)-challenged mice with RSV-specific immune globulin. J. Infect. Dis. 171:1468-1474.
22. Hayashi, N., D. Liu, B. Min, S. Z. Ben-Sasson, and W. E. Paul. 2002. Antigen challenge leads to in vivo activation and elimination of highly polarized TH1 memory T cells. Proc. Natl. Acad. Sci. USA 99:6187-6191.
23. Hoebee, B., E. Rietveld, L. Bont, M. Oosten, H. M. Hodemaekers, N. J. Nagelkerke, H. J. Neijens, J. L. Kimpen, and T. G. Kimman. 2003. Association of severe respiratory syncytial virus bronchiolitis with interleukin-4 and interleukin-4 receptor alpha polymorphisms. J. Infect. Dis. 187:2-11. (Pubitemid 36034465)
24. Johnson, T. R., R. A. Parker, J. E. Johnson, and B. S. Graham. 2003. IL-13 is sufficient for respiratory syncytial virus G glycoprotein-induced eosinophilia after respiratory syncytial virus challenge. J. Immunol. 170:2037-2045. (Pubitemid 36197425)
25. Kern, F., I. P. Surel, C. Brock, B. Freistedt, H. Radtke, A. Scheffold, R. Blasczyk, P. Reinke, J. Schneider-Mergener, A. Radbruch, P. Walden, and H. D. Volk. 1998. T-cell epitope mapping by flow cytometry. Nat. Med. 4:975-978. (Pubitemid 28364041)
26. + T-cell response to human cytomegalovirus: the 72-kilodalton major immediate-early protein revisited. J. Virol. 73:8179-8184.
27. Kim, C. K., S. W. Kim, C. S. Park, B. I. Kim, H. Kang, and Y. Y. Koh. 2003. Bronchoalveolar lavage cytokine profiles in acute asthma and acute bronchiolitis. J. Allergy Clin. Immunol. 112:64-71. (Pubitemid 36819808)
28. + cytotoxic T cells. J. Virol. 67:4086-4092.
29. Lee, F. E., E. E. Walsh, A. R. Falsey, M. E. Lumb, N. V. Okam, N. Liu, A. A. Divekar, C. B. Hall, and T. R. Mosmann. 2007. Human infant respiratory syncytial virus (RSV)-specific type 1 and 2 cytokine responses ex vivo during primary RSV infection. J. Infect. Dis. 195:1779-1788. (Pubitemid 46870251)
30. + T-lymphocyte immunodominance in respiratory syncytial virus infection. J. Virol. 81:2349-2358.
31. Legg, J. P., I. R. Hussain, J. A. Warner, S. L. Johnston, and J. O. Warner. 2003. Type 1 and type 2 cytokine imbalance in acute respiratory syncytial virus bronchiolitis. Am. J. Respir. Crit. Care Med. 168:633-639. (Pubitemid 37175965)
32. Liu, J., and M. Roederer. 2007. Differential susceptibility of leukocyte subsets to cytotoxic T cell killing: implications for HIV immunopathogenesis. Cytometry A 71:94-104.
33. Maecker, H. T., H. S. Dunn, M. A. Suni, E. Khatamzas, C. J. Pitcher, T. Bunde, N. Persaud, W. Trigona, T. M. Fu, E. Sinclair, B. M. Bredt, J. M. McCune, V. C. Maino, F. Kern, and L. J. Picker. 2001. Use of overlapping peptide mixtures as antigens for cytokine flow cytometry. J. Immunol. Methods 255:27-40. (Pubitemid 32695381)
34. Openshaw, P. J. 2001. Potential mechanisms causing delayed effects of respiratory syncytial virus infection. Am. J. Respir. Crit. Care Med. 163:S10-S13. (Pubitemid 32336737)
35. Openshaw, P. J., S. L. Clarke, and F. M. Record. 1992. Pulmonary eosinophilic response to respiratory syncytial virus infection in mice sensitized to the major surface glycoprotein G. Int. Immunol. 4:493-500.
36. Puthothu, B., M. Krueger, J. Forster, and A. Heinzmann. 2006. Association between severe respiratory syncytial virus infection and IL13/IL4 haplotypes. J. Infect. Dis. 193:438-441. (Pubitemid 43122344)
37. Roederer, M., and R. A. Koup. 2003. Optimized determination of T cell epitope responses. J. Immunol. Methods 274:221-228. (Pubitemid 36263057)
38. Román, M., W. J. Calhoun, K. L. Hinton, L. F. Avendano, V. Simon, A. M. Escobar, A. Gaggero, and P. V. Diaz. 1997. Respiratory syncytial virus infection in infants is associated with predominant Th-2-like response. Am. J. Respir. Crit. Care Med. 156:190-195. (Pubitemid 27293187)
39. + cytotoxic T lymphocyte epitope in the matrix protein of respiratory syncytial virus. Virology 337:335-343.
40. + T cell responses in an F1 hybrid mouse model of respiratory syncytial virus infection. Virology 362:314-319.
41. Sallusto, F., D. Lenig, R. Forster, M. Lipp, and A. Lanzavecchia. 1999. Two subsets of memory T lymphocytes with distinct homing potentials and effector functions. Nature 401:708-712.
42. + T lymphocytes downregulate T helper cell type 2 cytokine secretion and pulmonary eosinophilia during experimental murine respiratory syncytial virus infection. J. Exp. Med. 186:421-432.
43. Tang, Y. W., and B. S. Graham. 1997. T cell source of type 1 cytokines determines illness patterns in respiratory syncytial virus-infected mice. J. Clin. Investig. 99:2183-2191. (Pubitemid 27203774)
44. Tang, Y. W., K. M. Neuzil, J. E. Fischer, F. W. Robinson, R. A. Parker, and B. S. Graham. 1997. Determinants and kinetics of cytokine expression patterns in lungs of vaccinated mice challenged with respiratory syncytial virus. Vaccine 15:597-602.
45. Tregoning, J. S., Y. Yamaguchi, J. Harker, B. Wang, and P. J. Openshaw. 2008. The role of T cells in the enhancement of respiratory syncytial virus infection severity during adult reinfection of neonatally sensitized mice. J. Virol. 82:4115-4124.
46. Varga, S. M., and T. J. Braciale. 2002. RSV-induced immunopathology: dynamic interplay between the virus and host immune response. Virology 295:203-207.
47. Verginis, P., K. A. McLaughlin, K. W. Wucherpfennig, H. von Boehmer, and I. Apostolou. 2008. Induction of antigen-specific regulatory T cells in wildtype mice: visualization and targets of suppression. Proc. Natl. Acad. Sci. USA 105:3479-3484.
48. Waris, M. E., C. Tsou, D. D. Erdman, S. R. Zaki, and L. J. Anderson. 1996. Respiratory synctial virus infection in BALB/c mice previously immunized with formalin-inactivated virus induces enhanced pulmonary inflammatory response with a predominant Th2-like cytokine pattern. J. Virol. 70:2852-2860. (Pubitemid 26121897)
49. + T cells in the lungs following pulmonary virus infection. J. Immunol. 180: 2957-2966.
50. H1 cells have differential capacities for memory cell generation in vivo. Nat. Immunol. 3:852-858.
51. + T cells endowed with proliferative capacity. J. Exp. Med. 198:1909-1922.